用低剂量[F]FDG全身PET/CT对淋巴瘤治疗反应的评估
Clemens Mingels1,2, Kevin J Chung3, Hande Nalbant3
1Department of Radiology, University of California Davis, Sacramento, California; clemens.mingels@insel.ch.
概括
在[18F]FDG全身PET/CT中减少淋巴瘤评估的注射活性是可行的. 较低剂量维持了关键指标,如代谢性瘤体积和总损伤糖解,具有可比的治疗反应评估.
科学领域:
- 核医学就是核医学.
- 在瘤学瘤学.
- 放射化学 放射化学是指辐射化学.
背景情况:
- 全身 (TB) PET/CT提供了增强的灵敏度,使注射的放射性追踪剂活动的潜在减少成为可能.
- 在常规临床实践中,优化注射剂量对于患者安全和成本效益至关重要.
研究的目的:
- 确定使用结核病PET/CT.的淋巴瘤患者中期和治疗结束评估的注射[18F]FDG活性降低的下限.
- 评估剂量减少对定量成像参数和治疗反应评估的影响.
主要方法:
- 预期招募24名接受TB PET/CT治疗的淋巴瘤患者.
- 从注射后1个小时和2个小时获得的参考标准 (3.0 MBq/kg) 中,模拟减少了[18F]FDG活动 (1.0到0.125 MBq/kg).
- 对SUV,肝脏变化系数,代谢性瘤体积 (MTV),总损伤糖解 (TLG),瘤与背景比率 (TBRs),对比与噪声比率以及治疗响应的杜维尔标准的分析.
主要成果:
- SUVmax显示出与活动减少的增长趋势,但MTV和TLG仍然与参考标准相当.
- 随着活动的下降,肝脏变化系数显著增加,而TBRs显示微小的显著变化.
- 德奥维尔得分与参考标准保持相似,在注射后1小时降至0.25 MBq/kg,在注射后2小时降至1.0 MBq/kg.
结论:
- 注射的[18F]FDG活性可以在TB PET/CT中减少,以评估淋巴瘤治疗反应,而不会显著影响MTV,TBR或TLG.
- SUVmax和Deauville得分仍然是可靠的指标,在特定的降低剂量限制 (0.25 MBq/kg在1小时内,1.0 MBq/kg在2小时内) 内的反应.
- 这些发现支持[18F]FDG TB PET/CT在淋巴瘤管理中的剂量优化策略.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
相关概念视频
Positron Emission Tomography
5.5K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.5K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
235
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
235
